| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |